Surging Earnings Estimates Signal Upside for New York Times (NYT) Stock

13.08.25 18:20 Uhr

Werte in diesem Artikel
Aktien

49,60 EUR 0,65 EUR 1,33%

Indizes

1.498,7 PKT -0,8 PKT -0,05%

Investors might want to bet on New York Times Co. (NYT), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this newspaper publisher, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.For New York Times Co., there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:12 Month EPSCurrent-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $0.54 per share, which is a change of +20.0% from the year-ago reported number.Over the last 30 days, two estimates have moved higher for New York Times compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 10.2%.Current-Year Estimate RevisionsThe company is expected to earn $2.28 per share for the full year, which represents a change of +13.4% from the prior-year number.The revisions trend for the current year also appears quite promising for New York Times, with three estimates moving higher over the past month compared to no negative revisions. The consensus estimate has also received a boost over this time frame, increasing 6.16%.Favorable Zacks RankThe promising estimate revisions have helped New York Times earn a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.Bottom LineNew York Times shares have added 6.7% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The New York Times Company (NYT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: The New York Times und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf The New York Times

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf The New York Times

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu The New York Times Co.

Wer­bung

Analysen zu The New York Times Co.

DatumRatingAnalyst
06.11.2018The New York Times UnderweightBarclays Capital
09.02.2017The New York Times SellSingular Research
13.11.2015The New York Times Equal WeightBarclays Capital
10.04.2012The New York Times neutralUBS AG
11.01.2012The New York Times neutralUBS AG
DatumRatingAnalyst
07.07.2011The New York Times buyCitigroup Corp.
28.06.2011The New York Times kaufenDie Actien-Börse
14.06.2011The New York Times buyCitigroup Corp.
22.09.2008New York Times kaufenDie Actien-Börse
28.09.2005New York Times DepotaufnahmeVolksbank Karlsruhe
DatumRatingAnalyst
13.11.2015The New York Times Equal WeightBarclays Capital
10.04.2012The New York Times neutralUBS AG
11.01.2012The New York Times neutralUBS AG
28.10.2011The New York Times neutralCitigroup Corp.
22.09.2011The New York Times neutralUBS AG
DatumRatingAnalyst
06.11.2018The New York Times UnderweightBarclays Capital
09.02.2017The New York Times SellSingular Research
21.09.2010The New York Times sellUBS AG
20.04.2007New York Times underweightPrudential Financial
08.01.2007New York Times underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The New York Times Co. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen